DexCom earnings beat by $0.03, revenue topped estimates
Michael DePasquale, the Chief Executive Officer and Chairman of Bio-Key International Inc. (NASDAQ:BKYI), recently acquired 5,000 shares of the company’s common stock. This purchase took place on June 3, 2025, at $0.81 per share, totaling $4,050. The purchase price represents a significant discount from the 52-week high of $3.68, though InvestingPro analysis suggests the stock is currently overvalued despite an impressive gross profit margin of 80%. Following this transaction, DePasquale holds 44,519 shares directly, excluding options to purchase an additional 232 shares. With the company’s market cap at just $5 million and rapidly burning through cash, this insider purchase deserves deeper analysis. InvestingPro subscribers can access 11 additional key insights about BKYI’s financial health and valuation metrics in the comprehensive Pro Research Report.
In other recent news, BIO-key International reported its Q1 2025 earnings with revenue reaching $1.6 million, reflecting a 10% increase from the previous quarter, though it was a decrease from $2.2 million in the same period last year. The company experienced a net loss of $737,000 or $0.16 per share. Despite these challenges, BIO-key improved its cash position to over $3 million and reduced its note payable by more than half. A strategic partnership with Runlevel was announced, aiming to expand BIO-key’s cybersecurity solutions in Africa and Asia, starting with a deployment at a National Bank in Mozambique. The collaboration underscores the growing demand for advanced Identity and Access Management solutions in emerging markets. Additionally, BIO-key’s focus on biometric solutions and government contracts is expected to drive future growth, with potential significant renewals anticipated, such as a $3 million renewal from its largest customer in Q1 2026. Analyst feedback from Maxim Group indicates confidence in the company’s trajectory, highlighting its strategic pivot towards high-margin proprietary offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.